Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

NCT05768347

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, not recruiting

CD40 Agonist and PD-1 Inhibitor in HNSCC

NCT06159621

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

NCT03432806

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

Memorial Sloan Kettering Westchester Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, not recruiting

Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC

NCT05433116

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: University Hospital Ulm, Otolaryngology & Head and Neck Surgery Ulm, Baden-Wurttemberg, Germany

University Hospital Augsburg, Radiation Oncology Augsburg, Bavaria, Germany

University Hospital Erlangen, Radiation Oncology Erlangen, Bavaria, Germany

University Hospital Regensburg, Clinic and Polyclinic for Radiotherapy Regensburg, Bavaria, Germany

View Trial Details

Active, not recruiting

Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT05659251

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Active, not recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations: Shalby Hospital Ahmedabad, Gujarat, India

National Cancer Institute Jhajjar, Haryana, India

All India Institute of Medical Sciences New Delhi, India

PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India

View Trial Details

Active, not recruiting

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

NCT04624477

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +14 more
Locations: University of Calgary, Cumming School of Medicine Calgary, Alberta, Canada

University of British Columbia Vancouver, British Columbia, Canada

Nova Scotia Health Halifax, Nova Scotia, Canada

St. Joseph's Healthcare Hamilton, Ontario, Canada

View Trial Details

Active, not recruiting

Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer

NCT03271892

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Active, not recruiting

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

NCT05696444

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +40 more
Locations: City of Hope Duarte, California, United States

University of Chiago Chicago, Illinois, United States

Mount Sinai New York, United States

Duke Medical Center Durham, North Carolina, United States

View Trial Details

Active, not recruiting

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

NCT07248696

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancinoma (NPC), +12 more
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions